Monday, October 26, 2026 · Daily editionET --:--:--

Finished

Powered Assist to Improve Ambulation in Severe Lung Disease

NCT03790644 · West Park Healthcare Centre · Updated 4 May 2022

What is being tested
exoskeleton assist
For
Lung Disease Chronic
Kind of study
Tests a treatment or device on volunteers. No drug phase (a device or procedure study).
Who can join
Ages 18 years and older. About 6 people. The full rules are on the registry page.
Where
Canada
When
Starts or started 1 Aug 2018, ends 30 May 2021. Registered 31 Dec 2018.
Results
None posted yet.

In the researchers' words

Chronic respiratory disease (CRD) is among the most prevalent and growing diseases worldwide with disabling consequences. Many with a compromised respiratory system cannot support the metabolic energy demands of walking causing them to walk slowly and stop often. Those with CRD could receive substantial benefit from a powered wearable exoskeleton device that assumes part of the energy of walking. Assisting the legs will lower the metabolic energy demands, and therefore the ventilation required for exercise, thereby allowing them to walk faster and further. Proposed is a series of single-case experiments comparing walking endurance with and without a powered exoskeleton assist. The aim of this study is to determine the efficacy of an exoskeleton on walking endurance in ventilatory limited patients with CRD. An exoskeleton could be a novel immediate and long term strategy to augment walking as part of the spectrum of pulmonary rehabilitation and community reintegration.
ClinicalTrials.gov, NCT03790644

Sites

  • Westpark Health Care CentreToronto, Ontario, Canada